Monographie - Alprostadil

Poslední aktualizace :
27/11/2024

Alprostadil

Cheminė sandara

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Alfaprostin	Egiptas
Alistint	Peru
Alpros	Turkija
Alprostadil	Argentina, Čilė, Ekvadoras, Ispanija, Jungtinės Amerikos Valstijos, Kanada, Malaizija, Peru, Rumunija, Turkija, Vokietija
Alprostapint	Argentina, Austrija, Ekvadoras, Kolumbija, Peru, Vengrija
Alprostar	Italija
Aplicav	Brazilija
Cardiobon	Argentina, Peru
Caverject	Austrija, Belgija, Brazilija, Danija, Didžioji Britanija, Ispanija, Italija, Jungtinės Amerikos Valstijos, Kanada, Lenkija, Norvegija, Pietų Afrikos Respublika, Portugalija, Prancūzija, Slovėnija, Švedija, Šveicarija, Turkija
Edex	Prancūzija
Liple	Japonija
Minprog	Austrija, Vokietija
Ostapint	Meksikas, Peru
Palux	Japonija
Pridax	Austrija, Ispanija, Rumunija, Vokietija
Prolisina VR	Argentina
Prostandin	Japonija
Prostavasin	Austrija, Egiptas, Iranas, Italija, Lenkija, Liuksemburgas, Vengrija, Vokietija
Prostin VR	Australija, Belgija, Danija, Didžioji Britanija, Graikija, Iranas, Italija, Jungtinės Amerikos Valstijos, Kanada, Lenkija, Liuksemburgas, Malaizija, Norvegija, Olandija, Portugalija, Saudo Arabija, Suomija, Šveicarija, Venesuela, Vengrija
Prostine VR	Prancūzija
Vasaprostan	Rumunija

Bibliografija : Alprostadil

	tipas	leidinys
1072	Žurnalas	Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1899	Žurnalas	Trissel LA, Zhang Y. Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction. Int J Pharm Compound 2004 ; 8, 3: 231-235.
2003	Žurnalas	Paul M, Razzouq N, Tixier G, Astier A. Stability of prostaglandin E1 (PGE1) in aqueous solutions. EJHP Science 2005 ; 2: 31-36.
2090	Žurnalas	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2150	Žurnalas	Soli M, Bertaccini A, carparelli F, Gotti R, Cavrini V, Andrisano V, Martorana G. Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. J Urology 1998 ; 160; 2: 551-555.
2151	Žurnalas	Gatti R, Gotti R, Cavrini V, Soli M, Bertaccini A, Carparelli F. Stability study of prostaglandin E1 (PGE1) in physiological solutions by liquid chromatography (HPLC). Int J Pharm 1995 ; 115: 113-117.
3201	Žurnalas	Dice JE. Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit. J Pediatr Pharmacol Ther 2006 ; 11:233?6.
3448	Žurnalas	Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M. Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction. Ann Pharm Fr 2013 ; 71, 5: 358-363.
3761	Knyga	Chavan E. Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie. Master en pharmacie - University of Geneva 2014
3961	Žurnalas	McCluskey S.V,Kirkham K,Munson J.M. Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers. Int J Pharm Compound 2017 ; 21, 2: 150-153.
4069	Žurnalas	Palmero D, Chavan E, Berger-Gryllaki M, Tolsa J-F, Di Paolo E, Pannatier A, Henry H, Sadeghipour F. Stability of prostaglandin E1 solutions stored in polypropylene syringes for continuous intravenous administration to newborns. EJHP 2018 ; 25, e2
4389	Žurnalas	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4491	Žurnalas	De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 2020
4507	Žurnalas	Ross E, Salinas A, Petty K, Her C, Carpenter J. Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing. Am J Health-Syst Pharm 2020 ;77,23:1980-1985
4543	Žurnalas	Senarathna G, Strunk T, Petrovski M, Batty K. Physical compatibility of pentoxifylline and intravenous medications. Archives of Disease in Childhood 2018 ;104:292–295.
4570	Žurnalas	Greenhill K, Hornsby E, Gorman G. Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients. Pharmaceuticals 2019
4651	Žurnalas	De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A. Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 2021 ;180,1169–1176.
4837	Žurnalas	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales